These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7784124)

  • 21. The immune responses of sheep after DNA immunization with, Toxoplasma gondii MAG1 antigen-with and without co-expression of ovine interleukin 6.
    Hiszczyńska-Sawicka E; Akhtar M; Kay GW; Holec-Gasior L; Bickerstaffe R; Kur J; Stankiewicz M
    Vet Immunol Immunopathol; 2010 Aug; 136(3-4):324-9. PubMed ID: 20409592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha-galactosylceramide enhances protective immunity induced by DNA vaccine of the SAG5D gene of Toxoplasma gondii.
    Lu G; Zhou A; Meng M; Wang L; Han Y; Guo J; Zhou H; Cong H; Zhao Q; Zhu XQ; He S
    BMC Infect Dis; 2014 Dec; 14():3862. PubMed ID: 25527277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of protective immunity induced by DNA vaccination with genes encoding Toxoplasma gondii GRA17 and GRA23 against acute toxoplasmosis in mice.
    Zhu WN; Wang JL; Chen K; Yue DM; Zhang XX; Huang SY; Zhu XQ
    Exp Parasitol; 2017 Aug; 179():20-27. PubMed ID: 28625894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Veterinary vaccines against Toxoplasma gondii.
    Innes EA; Bartley PM; Maley S; Katzer F; Buxton D
    Mem Inst Oswaldo Cruz; 2009 Mar; 104(2):246-51. PubMed ID: 19430650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary and secondary responses of the ovine lymph node to Toxoplasma gondii: cell output in efferent lymph and parasite detection.
    Buxton D; Thomson KM; Maley S; Wastling JM; Innes EA; Panton WR; Nicoll S
    J Comp Pathol; 1994 Oct; 111(3):231-41. PubMed ID: 7836566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxoplasma gondii: protective immunity induced by rhoptry protein 9 (TgROP9) against acute toxoplasmosis.
    Chen J; Zhou DH; Li ZY; Petersen E; Huang SY; Song HQ; Zhu XQ
    Exp Parasitol; 2014 Apr; 139():42-8. PubMed ID: 24602875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora.
    Innes EA; Vermeulen AN
    Parasitology; 2006; 133 Suppl():S145-68. PubMed ID: 17274844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Veterinary vaccines against toxoplasmosis.
    Hiszczyńska-Sawicka E; Gatkowska JM; Grzybowski MM; Długońska H
    Parasitology; 2014 Sep; 141(11):1365-78. PubMed ID: 24805159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mast cell activator compound 48/40 is not an effective adjuvant for UV-attenuated Toxoplasma gondii vaccine.
    Li X; Chen S; Huang S; Lu F
    Parasitol Res; 2017 Aug; 116(8):2347-2353. PubMed ID: 28573462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxoplasma gondii immune mapped protein-1 (TgIMP1) is a novel vaccine candidate against toxoplasmosis.
    Cui X; Lei T; Yang D; Hao P; Li B; Liu Q
    Vaccine; 2012 Mar; 30(13):2282-7. PubMed ID: 22310204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant Toxoplasma gondii phosphoglycerate mutase 2 confers protective immunity against toxoplasmosis in BALB/c mice.
    Wang HL; Wen LM; Pei YJ; Wang F; Yin LT; Bai JZ; Guo R; Wang CF; Yin GR
    Parasite; 2016; 23():12. PubMed ID: 26984115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current status of toxoplasmosis vaccine development.
    Kur J; Holec-Gasior L; Hiszczyńska-Sawicka E
    Expert Rev Vaccines; 2009 Jun; 8(6):791-808. PubMed ID: 19485758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxoplasma gondii: protective immunity against experimental toxoplasmosis induced by a DNA vaccine encoding the perforin-like protein 1.
    Yan HK; Yuan ZG; Petersen E; Zhang XX; Zhou DH; Liu Q; He Y; Lin RQ; Xu MJ; Chen XL; Zhong XL; Zhu XQ
    Exp Parasitol; 2011 May; 128(1):38-43. PubMed ID: 21310148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination of pigs with the S48 strain of Toxoplasma gondii--safer meat for human consumption.
    Burrells A; Benavides J; Cantón G; Garcia JL; Bartley PM; Nath M; Thomson J; Chianini F; Innes EA; Katzer F
    Vet Res; 2015 May; 46(1):47. PubMed ID: 25928856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxoplasma gondii: prototype immunization of lambs against formation of muscle and brain cysts.
    Falcón J; Freyre A
    Vet Parasitol; 2009 Dec; 166(1-2):15-20. PubMed ID: 19729248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SAG5B and SAG5C combined vaccine protects mice against Toxoplasma gondii infection.
    Lu G; Zhou J; Zhou A; Han Y; Guo J; Song P; Zhou H; Cong H; Hou M; Wang L; He S
    Parasitol Int; 2017 Oct; 66(5):596-602. PubMed ID: 28602862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovine toxoplasmosis: transmission, clinical outcome and control.
    Buxton D; Maley SW; Wright SE; Rodger S; Bartley P; Innes EA
    Parassitologia; 2007 Dec; 49(4):219-21. PubMed ID: 18689230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decoquinate and the control of experimental ovine toxoplasmosis.
    Buxton D; Brebner J; Wright S; Maley SW; Thomson KM; Millard K
    Vet Rec; 1996 May; 138(18):434-6. PubMed ID: 8735260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice.
    Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ
    Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of immune responses induced by SAG1 and MIC3 vaccine cocktails against Toxoplasma gondii.
    Fang R; Feng H; Hu M; Khan MK; Wang L; Zhou Y; Zhao J
    Vet Parasitol; 2012 Jun; 187(1-2):140-6. PubMed ID: 22336771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.